BICO Group AB - Company Profile
Powered by 
All the data and insights you need on BICO Group AB in one report.
$295
- Save hours of research time and resources with
our up-to-date BICO Group AB Strategy Report
- Understand BICO Group AB position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
BICO Group AB (BICO AB) is engaged in the development and marketing of bioprinting technologies which enable researchers to print three dimensional (3D) human organs and tissues. The company’s product portfolio encompasses bioprinters, drug screening, biodispensing solutions and automated non-contact plate washer and liquid dispenser, among others. It also offers spheroOne, the single large-particle sorter and dispenser platform. BICO caters to research institutions, pharmaceutical, biopharmaceutical, automotive, and cosmetic companies. The company sells its products through direct sales force in the US and Sweden and through an extensive network of distributors in Europe (excluding Sweden), and Asia-Pacific. It operates a subsidiary in the US. BICO AB is headquartered in Goteborg, Sweden.
Headquarters
Sweden
Address
Langfilsgatan 9, Goeteborg, 41277
Website
bico.com
Telephone
46 31 12874646
No of Employees
884
Industry
Medical Equipment
Ticker Symbol & Exchange
BICO (STO)
Revenue (2022)
$212.1M
6.1%
(2022 vs 2021)
EPS
XYZ
Net Income (2022)
XYZ
-138.1%
(2022 vs 2021)
Market Cap*
$304.9M
Net Profit Margin (2022)
XYZ
-124.5%
(2022 vs 2021)
* As of and is in US$
BICO Group AB premium industry data and analytics
Products and Services
| Products | Brands |
|---|---|
| 3D Bioprinters | Inkredible |
| Bioprinters | Bio X |
| Kits | Cellink |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2023 | Contracts/Agreements | In November, the company entered an agreement with Ossiform to market a ready-to-print bioink based on Ossiform’s biomaterial. |
| 2023 | Contracts/Agreements | In October, the company partnered with the University of California, San Diego to develop a 3D bioprinting Centre of Excellence. |
| 2023 | Contracts/Agreements | In October, the company partnered with Carcinotech to develop 3D bioprinted tumor models based on cancer cell lines. |
Competitor Comparison
| Key Parameters | BICO Group AB | Abbott Laboratories | Medtronic Plc | Align Technology Inc | DexCom Inc |
|---|---|---|---|---|---|
| Headquarters | Sweden | United States of America | Ireland | United States of America | United States of America |
| City | Goeteborg | Abbott Park | Dublin | Tempe | San Diego |
| State/Province | - | Illinois | - | Arizona | California |
| No. of Employees | 884 | 114,000 | 95,000 | 21,610 | 9,600 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Carsten Browall | Chairman | Executive Board | 2019 | 65 |
| Hector Martinez, Ph.D. | Director; Chief Technology Officer; Executive Vice President | Executive Board | 2016 | 38 |
| Maria Forss | Chief Executive Officer; President | Senior Management | 2023 | - |
| Jacob Thordenberg | Chief Financial Officer | Senior Management | 2023 | 38 |
| Marius Balger | Chief Operating Officer | Senior Management | 2023 | 55 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward